Last updated on April 2016

An Open-Label Study of Dupilumab In Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials


Brief description of study

An Open-Label Study of Dupilumab In Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials

Detailed Study Description

The study doctor and Regeneron are conducting this research study of an investigational drug called dupilumab. The main purpose of this study is to collect long term safety data on adult subjects with moderate-to-severe atopic dermatitis who have previously been administered dupilumab.

Clinical Study Identifier: TX143375

Find a site near you

Start Over

IACT Health

800 Talbotton Road Columbus, GA USA
  Connect »